Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Millendo Therapeutics Inc (MLND)

1.86   0.01 (0.54%) 08-13 16:00
Open: 1.87 Pre. Close: 1.85
High: 1.87 Low: 1.82
Volume: 255,122 Market Cap: 35M
Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, engages in the development of various treatments for orphan endocrine diseases in the United States. The company's lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; and nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia. Millendo Therapeutics, Inc. is headquartered in Ann Arbor, Michigan.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.872 - 1.881 1.881 - 1.889
Low: 1.798 - 1.809 1.809 - 1.818
Close: 1.844 - 1.861 1.861 - 1.875

Technical analysis

as of: 2020-08-13 4:36:21 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 2.50     One year: 2.92
Support: Support1: 1.78    Support2: 1.55
Resistance: Resistance1: 2.14    Resistance2: 2.50
Pivot: 1.84
Moving Average: MA(5): 1.88     MA(20): 1.85
MA(100): 2.18     MA(250): 5.21
MACD: MACD(12,26): -0.01     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 45.18     %D(3): 44.29
RSI: RSI(14): 49.86
52-week: High: 9.88  Low: 1.26  Change(%): -73.4
Average Vol(K): 3-Month: 143336  10-Days: 45495

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
MLND has closed below upper band by 43.3%. Bollinger Bands are 85.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to MLND's normal range. The bands have been in this narrow range for 25 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 12 Aug 2020
Analysts Offer Insights on Healthcare Companies: Millendo Therapeutics (NASDAQ: MLND) and Entasis Therapeutics Holdings (NASDAQ: ETTX) - Analyst Ratings

Mon, 10 Aug 2020
Earnings Scorecard & Analyst Reports for Millendo Therapeutics (NASDAQ:MLND) - Stock Market Daily

Mon, 10 Aug 2020
Millendo Therapeutics Reports Second Quarter 2020 Operating and Financial Results - Odessa American

Tue, 28 Jul 2020
Here is a bargain stock you should look at : Millendo Therapeutics, Inc. (MLND) - Marketing Sentinel

Mon, 27 Jul 2020
Millendo Therapeutics, Inc. (MLND) Everything Investors Need To Know - The News Heater

Thu, 23 Jul 2020
Millendo Therapeutics Inc. (MLND) 14-day ATR is 0.23: This Stock is Set to Soar Above its Peers - News Daemon

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 19
Shares Float (M) 13
% Held by Insiders 11.30
% Held by Institutions 65.47
Shares Short (K) 1,000
Shares Short P. Month (K) 561

Stock Financials

EPS -3.084
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 2.830
Profit Margin
Operating Margin
Return on Assets (ttm) -41.2
Return on Equity (ttm) -78.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.461
Qtrly Earnings Growth
Operating Cash Flow (M) -41
Levered Free Cash Flow (M) -23

Stock Valuations

PE Ratio -0.60
PEG Ratio
Price to Book value 0.66
Price to Sales
Price to Cash Flow -0.87

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.